Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Canopy Growth Corporation
CGC
$0.942
Name : Canopy Growth Corporation
Sector : Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Mark. Cap: $423,015,136.00
EPSttm : -0.47
finviz dynamic chart for CGC
Canopy Growth Corporation
$0.942
1.35%
$0.013
CGC — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

6.65

Margin Of Safety %

Put/Call OI Ratio

0.14

EPS Next Q Diff

0.01

EPS Last/This Y

EPS This/Next Y

-0.1

Price

0.94

Target Price

1.58

Analyst Recom

2.5

Performance Q

-0.47

Upside

-1,775.5%

Beta

0.79

Ticker: CGC




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-08-28CGC1.010.140.17293258
2026-08-31CGC0.9950.140.23289722
2026-09-01CGC0.97220.140.16291957
2026-09-02CGC0.9730.140.09293571
2026-09-03CGC0.97870.140.03294218
2026-09-04CGC0.97450.140.07295178
2026-09-08CGC0.96850.140.05291332
2026-09-09CGC0.95730.140.31296318
2026-09-10CGC0.9240.140.29296868
2026-09-11CGC0.92530.140.16297262
2026-09-14CGC0.93530.140.09295228
2026-09-15CGC0.92340.130.22297361
2026-09-16CGC0.91510.130.13298030
2026-09-17CGC0.9340.130.08299318
2026-09-18CGC0.93720.130.08299681
2026-09-21CGC0.92330.142.62287293
2026-09-22CGC0.9690.140.06292020
2026-09-23CGC0.94440.140.39301244
2026-09-24CGC0.93330.140.02305471
2026-09-25CGC0.94020.140.10306179
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-08-28CGC1.00-100.0- -0.07
2026-08-31CGC0.99-100.0- -0.07
2026-09-01CGC0.98-100.0- -0.07
2026-09-02CGC0.97-100.0- -0.07
2026-09-03CGC0.97-100.0- -0.07
2026-09-04CGC0.97-100.0- -0.07
2026-09-08CGC0.97-100.0- -0.07
2026-09-09CGC0.96-100.0- -0.07
2026-09-10CGC0.92-100.0- -0.07
2026-09-11CGC0.93-100.0- -0.07
2026-09-14CGC0.94-100.0- -0.07
2026-09-15CGC0.92-100.0- -0.07
2026-09-16CGC0.92-100.0- -0.07
2026-09-17CGC0.93-100.0- -0.07
2026-09-18CGC0.94-100.0- -0.07
2026-09-21CGC0.92-100.0- -0.07
2026-09-22CGC0.97-100.0- -0.07
2026-09-23CGC0.94-100.0- -0.07
2026-09-24CGC0.93-100.0- -0.07
2026-09-25CGC0.94-100.0- -0.07
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-08-28CGC-24.860.005.92
2026-08-31CGC-24.860.005.92
2026-09-01CGC-12.200.005.94
2026-09-02CGC-12.200.005.94
2026-09-03CGC-12.200.005.94
2026-09-04CGC-12.200.005.94
2026-09-08CGC-12.200.005.94
2026-09-09CGC-12.200.005.94
2026-09-10CGC-12.200.005.94
2026-09-11CGC-12.200.006.19
2026-09-14CGC-12.200.026.19
2026-09-15CGC-12.420.026.19
2026-09-16CGC-12.420.026.19
2026-09-17CGC-12.420.026.19
2026-09-18CGC-13.360.026.19
2026-09-21CGC-13.360.026.19
2026-09-23CGC-13.360.026.19
2026-09-24CGC-13.360.026.19
2026-09-25CGC-13.360.026.65
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS​

-0.02

Avg. EPS Est. Current Quarter

-0.03

Avg. EPS Est. Next Quarter

-0.01

Insider Transactions

-13.36

Institutional Transactions

0.02

Beta

0.79

Average Sales Estimate Current Quarter

57

Average Sales Estimate Next Quarter

63

Fair Value

Quality Score

37

Growth Score

31

Sentiment Score

24

Actual DrawDown %

99.4

Max Drawdown 5-Year %

-99.5

Target Price

1.58

P/E

Forward P/E

PEG

P/S

1.87

P/B

0.82

P/Free Cash Flow

EPS

-0.45

Average EPS Est. Cur. Y​

-0.07

EPS Next Y. (Est.)

-0.17

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-79.75

Relative Volume

0.31

Return on Equity vs Sector %

-60.1

Return on Equity vs Industry %

-39.8

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.08

EBIT Estimation

◆ CGC Healthcare
$0.94
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
0/20
Pullback
20/25
Volume
11/15
Valuation
12/20
TP/AR
1/10
Options
8/10
RSI
46.4
Range 1M
15.1%
Sup Dist
2%
🚀
Momentum Growth
Ride accelerating trends
N/A
35 /100
WEAK
Momentum
0/25
Growth
25/30
Estimates
0/20
Inst/Vol
2/15
Options
8/10
EPS Yr
83.7%
EPS NY
23.3%
52W%
6.2%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +68.1% upside
Quality
3/30
Valuation
14/30
Growth
21/25
Stability
6/10
LT Trend
1/5
Upside
+68.1%
Quality
37
CGC — P/E HistoricalDrug Manufacturers - Specialty & Generic
Canopy Growth Corporation
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 1128
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel. It also provides vaporizers and accessories; dried flower and pre-rolled joints, oil, and vapes and beverages; extracts and concentrates, such as softgel capsules; and cannabis edibles, including gummies. In addition, the company operates e-commerce shop; medical cannabis online distribution platform; and an online medical cannabis clinic. It sells its products under the Tweed, 7ACRES, Deep Space, HiWay, Maitri, Twd., Spectrum Therapeutics, Canopy Medical, Abba Medix, Storz & Bickel, Wana, and Claybourne, Apollo, Canada House, R'belle, LowKey, MTL Cannabis, DeeLish, DOJA brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
CGC

Latest News

—
Caricamento notizie per CGC…
stock quote shares CGC – Canopy Growth Corporation Stock Price stock today
news today CGC – Canopy Growth Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch CGC – Canopy Growth Corporation yahoo finance google finance
stock history CGC – Canopy Growth Corporation invest stock market
stock prices CGC premarket after hours
ticker CGC fair value insiders trading